| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| Alcon Inc. | ROCLATAN - (Mercury 3) | Open Angle Glaucoma | Phase 3 | Data Released | ophthalmic | Opthalmic |
| Alcon Inc. | AR-1105 (dexamethasone intravitreal implant) | Macular edema due to RVO (retinal vein occlusion) | Phase 2 | Trial Completed | Intravitreal | Opthalmic |
| Aldeyra Therapeutics Inc. | Ganetespib (ADX-1612) | Ovarian cancer | Phase 2 | Intravenous | Oncology | |
| Aldeyra Therapeutics Inc. | Ganetespib (ADX-1612) | Post-transplant lymphoproliferative disorder | Phase 2 | Intravenous | Oncology | |
| Aldeyra Therapeutics Inc. | ADX-629 | Psoriasis / atopic asthma / COVID-19 | Phase 2 | Trial Discontinued | Oral | COVID-19 |
| Aldeyra Therapeutics Inc. | Ganetespib (ADX-1612) | Ovarian cancer | Phase 2 | Intravenous | Oncology | |
| Aldeyra Therapeutics Inc. | ADX-629 | Psoriasis / atopic asthma / COVID-19 | Phase 2 | Trial Discontinued | Oral | COVID-19 |
| Aldeyra Therapeutics Inc. | ADX-629 | Moderate / Acute Alcoholic Hepatitis | Phase 2 | Trial Discontinued | Oral | Gastroenterology |